NIFTY 50

Cipla remains top pick, Sun Pharma upgraded to add from sell: Kotak Institutional equities

Updated : February 19, 2019 02:48 PM IST

US businesses of pharma companies bottomed out and price erosion was more manageable,
Currently, the brokerage prefers Cipla and Torrent pharma, which have a strong domestic franchise underpinning the valuation and providing downside support
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more

You May Also Like

Live TV